These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 30785996

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Variation in sensitivity and rate of change in body composition: steps toward individualizing transgender care.
    van Velzen DM, Nota NM, Simsek S, Conemans EB, T'Sjoen G, den Heijer M.
    Eur J Endocrinol; 2020 Nov; 183(5):529-536. PubMed ID: 33071222
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
    Naderpoor N, Shorakae S, Abell SK, Mousa A, Joham AE, Moran LJ, Stepto NK, Spritzer PM, Teede HJ, de Courten B.
    J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
    [Abstract] [Full Text] [Related]

  • 5. Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen.
    van Velzen DM, Paldino A, Klaver M, Nota NM, Defreyne J, Hovingh GK, Thijs A, Simsek S, T'Sjoen G, den Heijer M.
    J Clin Endocrinol Metab; 2019 Jun 01; 104(6):1937-1947. PubMed ID: 30602016
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D.
    Sollid ST, Hutchinson MY, Berg V, Fuskevåg OM, Figenschau Y, Thorsby PM, Jorde R.
    Eur J Endocrinol; 2016 Apr 01; 174(4):445-52. PubMed ID: 26733479
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. FREE AND BIOAVAILABLE 25-HYDROXYVITAMIN D LEVELS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM.
    Wang X, Shapses SA, Al-Hraishawi H.
    Endocr Pract; 2017 Jan 01; 23(1):66-71. PubMed ID: 27682354
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.
    Denburg MR, Kalkwarf HJ, de Boer IH, Hewison M, Shults J, Zemel BS, Stokes D, Foerster D, Laskin B, Ramirez A, Leonard MB.
    Pediatr Nephrol; 2013 Sep 01; 28(9):1843-53. PubMed ID: 23728936
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development and analytical validation of a novel bioavailable 25-hydroxyvitamin D assay.
    Berg AH, Tavasoli M, Lo AS, Burnett-Bowie SM, Bhan I, Karumanchi SA, Kalim S, Zhang D, Zhao S, Thadhani RI.
    PLoS One; 2021 Sep 01; 16(7):e0254158. PubMed ID: 34242315
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prognostic value of circulating vitamin D binding protein, total, free and bioavailable 25-hydroxy vitamin D in patients with colorectal cancer.
    Yang L, Chen H, Zhao M, Peng P.
    Oncotarget; 2017 Jun 20; 8(25):40214-40221. PubMed ID: 28388568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.